{"entity":{"type":"insider","cik":"0001540660","url":"/insider/0001540660","json_url":"/insider/0001540660.json","name":"Bryan Jones W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2015-03-26","last":"2017-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Bryan Jones W.","source":"filing","n_filings":3,"first_seen":"2015-03-26","last_seen":"2017-08-07"}],"transactions":[{"id":4287614,"accession":"0001171843-17-004784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-17-004784","line_url":"/filing/0001171843-17-004784#line-1","is_derivative":false,"issuer_cik":"0001365216","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001365216","owner_cik":"0001540660","owner_name":"Bryan Jones W.","owner_display_name":"Bryan Jones W.","owner_url":"/insider/0001540660","role":"Officer (Sr. Vice Pres., BD & Licensing)","role_mark":"O","role_mark_label":"Officer (Sr. Vice Pres., BD & Licensing)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. Vice Pres., BD & Licensing","security_title":"Common Stock, Class A","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4700.0,"shares_display":"4,700","price_per_share":10.6,"price_display":"10.60","price_state":"stated","total_value":49820.0,"total_display":"49,820.00","total_whole":"49,820","shares_owned_after":4700.0,"shares_owned_after_display":"4,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-04","filed_date":"2017-08-07","scope":"insider"},{"id":8779756,"accession":"0001104659-15-024705","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-024705","line_url":"/filing/0001104659-15-024705#line-2","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001540660","owner_name":"Bryan Jones W.","owner_display_name":"Bryan Jones W.","owner_url":"/insider/0001540660","role":"Officer (VP of Business Development)","role_mark":"O","role_mark_label":"Officer (VP of Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6712.0,"shares_display":"6,712","price_per_share":12.0153,"price_display":"12.02","price_state":"stated","total_value":80646.6936,"total_display":"80,646.69","total_whole":"80,647","shares_owned_after":67980.0,"shares_owned_after_display":"67,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-30","filed_date":"2015-03-31","scope":"insider"},{"id":8914923,"accession":"0001104659-15-023152","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-15-023152","line_url":"/filing/0001104659-15-023152#line-3","is_derivative":false,"issuer_cik":"0001356576","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001356576","owner_cik":"0001540660","owner_name":"Bryan Jones W.","owner_display_name":"Bryan Jones W.","owner_url":"/insider/0001540660","role":"Officer (VP of Business Development)","role_mark":"O","role_mark_label":"Officer (VP of Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":22800.0,"total_display":"22,800.00","total_whole":"22,800","shares_owned_after":67980.0,"shares_owned_after_display":"67,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-24","filed_date":"2015-03-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001365216","name":"Sucampo Pharmaceuticals, Inc.","url":"/issuer/0001365216","role":"Officer (Sr. Vice Pres., BD & Licensing)","n_filings":1,"first_seen":"2017-08-07","last_seen":"2017-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001356576","name":"SUPERNUS PHARMACEUTICALS INC","url":"/issuer/0001356576","role":"Officer (VP of Business Development)","n_filings":2,"first_seen":"2015-03-26","last_seen":"2015-03-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001540660","retrieved_at":"2026-08-23T16:52:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}